Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

198
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
198
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

223
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
223

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mesotherapy With Lidocaine and Ketamine in Complex Regional Pain Syndrome Type 1: A Randomized Double-Blind Trial.

Pain practice : the official journal of World Institute of Pain·2026
Same author

Toxic and explosive risks in pharmacy: an underestimated reality.

Presse medicale (Paris, France : 1983)·2026
Same author

Correction: Filali et al. Morphological and Mechanical Characterization of Extracellular Vesicles and Parent Human Synoviocytes under Physiological and Inflammatory Conditions. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 13201.

International journal of molecular sciences·2026
Same author

The Dynamic Effects of Transposon Insertions on <i>AuxRP1</i> Transcription During Vegetative Development in <i>Zea mays</i>.

microPublication biology·2025
Same author

Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent.

European journal of hospital pharmacy : science and practice·2025
Same author

Real-time monitoring by interferometric light microscopy of phage suspensions for personalised phage therapy.

Scientific reports·2024

Related Experiment Video

Updated: Sep 9, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K

Smart Formulation: AI-Driven Web Platform for Optimization and Stability Prediction of Compounded Pharmaceuticals

Artur Grigoryan1, Stefan Helfrich2, Valentin Lequeux1

  • 1Fripharm®, Pharmacy Department, Groupe Hospitalier Centre Edouard Herriot, Hospices Civils de Lyon, 5, Place d'Arsonval, F-69437 Lyon, France.

Pharmaceuticals (Basel, Switzerland)
|August 28, 2025
PubMed
Summary

Smart Formulation, an AI platform, predicts Beyond Use Dates (BUDs) for compounded medications. It helps pharmacists optimize drug stability by considering molecular, formulation, and environmental factors, improving patient care.

Keywords:
beyond-use date predictiondrug compoundingexcipientsmachine learningmolecular descriptorspharmaceutical stability

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.2K

Related Experiment Videos

Last Updated: Sep 9, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.2K

Area of Science:

  • Computational pharmaceutics
  • Artificial intelligence in drug formulation
  • Predictive modeling for drug stability

Background:

  • Compounded oral solid dosage forms require accurate Beyond Use Dates (BUDs).
  • Current methods for determining BUDs can be time-consuming and costly.
  • Optimizing extemporaneous preparation stability is crucial for patient safety.

Purpose of the Study:

  • To develop an AI-based decision-support tool, Smart Formulation, for predicting BUDs.
  • To integrate molecular, formulation, and environmental parameters for stability prediction.
  • To assist pharmacists in optimizing the stability of compounded medications.

Main Methods:

  • A tree ensemble regression model was trained on 55 experimental BUD values.
  • Formulations were encoded with molecular descriptors, excipient composition, packaging, and storage conditions.
  • The model was implemented using the KNIME platform for cheminformatics and machine learning integration.

Main Results:

  • Excipient type, number, and environmental conditions significantly impact API stability.
  • Lower LogP values and single excipients (e.g., cellulose, silica, sucrose, mannitol) correlated with greater stability.
  • HPMC and lactose accelerated degradation; using two excipients often reduced BUDs.

Conclusions:

  • Smart Formulation provides a valuable computational tool for pharmaceutics, linking formulation design to compounding needs.
  • The platform offers a scalable, cost-effective alternative to traditional stability testing.
  • Implementation can mitigate drug shortages, standardize formulations, and enhance patient care.